High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma-Reference-Cited by-同舟云学术

High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma

Published:2007-01-01 Issue:1 Volume:109 Page:60-67
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Vignot Steéphane,Mounier Nicolas,Larghero Jeérôme,Brice Pauline,Quero Laurent,de Bazelaire Ceédric,Ertault Marjan,Brière Josette,Madelaine Isabelle,Gisselbrecht Christian

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. High-dose therapy for indolent lymphoma

2. World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

3. Follicular Lymphoma International Prognostic Index

4. Current treatment of follicular non-Hodgkin's lymphoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Y90-Ibritumomab tiuxetan (Y90-IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05);Hematological Oncology;2016-09-28

2. Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients;Hematological Oncology;2016-07-05

3. High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Blood and Marrow Transplantation Registry;Biology of Blood and Marrow Transplantation;2012-05

4. 90Y Ibritumomab Tiuxetan (Zevalin) Combined With BEAM (Z -BEAM) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed or Refractory Low-grade CD20-positive B-cell Lymphoma. A GELA Phase II Prospective Study;Clinical Lymphoma Myeloma and Leukemia;2011-04

5. The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Follicular Lymphoma: An Evidence-Based Review;Biology of Blood and Marrow Transplantation;2010-04